Provera 5. 10 Mg Tablets 5mg. 10 mg Tablets.
PDF Leaflet Revision Date: 20 October 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Dysfunctional uterine bleeding, endometriosis, menopausal symptoms.
Dosage (summary)
5-10 mg for 5-10 days; 10 mg three times daily for endometriosis.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy; not recommended during breastfeeding.
Key Drug Interactions
- Aminoglutethimide
- CYP3A4 inducers/inhibitors
Contraindications
- Hypersensitivity
- Thromboembolic disorders
- Liver disease
- Malignancy
- Undiagnosed vaginal bleeding
- Pregnancy
Common side effects
- Dysfunctional uterine bleeding
- Headache
- Nausea
Counselling Points
- Monitor for mood changes
- Avoid if pregnant or breastfeeding
- Inform lab of use before tests
Serious warnings
- Risk of thromboembolic events
- May cause depression
- Fluid retention
Important Disclaimer
The Provera 5. 10 Mg Tablets 5mg. 10 mg Tablets. professional information leaflet below is the property of Pfizer Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
